APA (7th ed.) Citation

Takeuchi, T., Tanaka, Y., Yamanaka, H., Yamaoka, K., Sugiyama, N., Iikuni, N., . . . Fleischmann, R. (2026). Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis. Rheumatology & Therapy, 13(2), 423. https://doi.org/10.1007/s40744-025-00823-0

Chicago Style (17th ed.) Citation

Takeuchi, Tsutomu, et al. "Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis." Rheumatology & Therapy 13, no. 2 (2026): 423. https://doi.org/10.1007/s40744-025-00823-0.

MLA (9th ed.) Citation

Takeuchi, Tsutomu, et al. "Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis." Rheumatology & Therapy, vol. 13, no. 2, 2026, p. 423, https://doi.org/10.1007/s40744-025-00823-0.